Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature

Exp Hematol. 2020 Oct:90:65-71.e1. doi: 10.1016/j.exphem.2020.09.184. Epub 2020 Sep 15.

Abstract

The finding that transformed mouse B-1 and B-2 progenitors give rise to B-cell acute lymphoblastic leukemias (B-ALLs) with varied aggressiveness suggests that B-cell lineage might also be a factor in the initiation and progression of pediatric B-ALLs in humans. If this is the case, we hypothesized that human pediatric B-ALLs would share gene expression patterns with mouse B-1 or B-2 progenitors. We tested this premise by deriving a distinct 30-gene B-1 and B-2 progenitor signature that was applied to a microarray data set of human pediatric ALLs. Cluster analysis revealed that CRLF2, E2A-PBX1, ERG, and ETV6-RUNX1 leukemias were B-1-like, whereas BCR-ABL1, hyperdiploid, and MLL leukemias were B-2-like. Examination of the 30-gene signature in two independent data sets of pediatric ALLs supported this result. Our data suggest that common genetic subtypes of human ALL have their origin in the B-1 or B-2 lineage.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Child
  • Gene Expression Profiling*
  • Gene Expression Regulation, Leukemic*
  • Humans
  • Mice
  • Neoplasm Proteins* / biosynthesis
  • Neoplasm Proteins* / genetics
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / classification
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / metabolism
  • Transcriptome*

Substances

  • Neoplasm Proteins